High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer

PURPOSE: The enhancer of zeste homologue 2 (EZH2) is a catalytic subunit of the polycomb repressive complex 2, a highly conserved histone methyltransferase. EZH2 overexpression has been implicated in various malignancies, including breast cancer, where is associated with poor outcomes. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Si-Hyong, Lee, Jong Eun, Oh, Mee-Hye, Lee, Ji-Hye, Cho, Hyun Deuk, Kim, Kyung-Ju, Kim, Sung Yong, Han, Sun Wook, Kim, Han Jo, Bae, Sang Byung, Lee, Hyun Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822107/
https://www.ncbi.nlm.nih.gov/pubmed/27066096
http://dx.doi.org/10.4048/jbc.2016.19.1.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822107/
https://www.ncbi.nlm.nih.gov/pubmed/27066096
http://dx.doi.org/10.4048/jbc.2016.19.1.53

Ejemplares similares